MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/lary.26083

Медицинская библиотека · The Laryngoscope · 2016

Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.

Platek Alexis J, Jayaprakash Vijayvel, Merzianu Mihai, Platek Mary E, Cohan David M, Hicks Wesley L, Marimuthu Sathiya P, Winslow Timothy B, Gupta Vishal, Arshad Hassan, Kuriakose Moni A, Dibaj Shiva, Marshall James R, Reid Mary E, Warren Graham W, Singh Anurag K

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES/HYPOTHESIS: The effect of smoking and human papillomavirus (HPV) on overall survival (OS) of oropharyngeal squamous cell carcinoma (OPSCC) patients undergoing concurrent chemotherapy (CCRT) remains unclear.

STUDY

DESIGN

Retrospective review.

METHODS

Clinical characteristics of OPSCC patients treated between 2008 and 2015 with CCRT were abstracted from medical records. OS curves and multivariate cox proportional hazard ratios (HRs) were examined.

RESULTS

Of 120 evaluable patients, 71% had HPV+ tumors. Median follow-up duration for the entire cohort was 41.5 months (range = 6-88 months). HPV+ current smokers experienced significantly worse 5-year OS (73% alive vs. 36% alive, P = .01) and there was a similar trend in HPV- current smokers (66% alive vs. 31% alive, P = .28) compared to former/never smokers undergoing CCRT. In a multivariate cox proportional hazard model adjusted for age, gender, and overall tumor stage, HPV+ current smokers experienced nearly a fourfold increase in overall mortality in comparison to HPV+ never/former smokers (HR = 3.68, 95% CI = 1.35-10.0). Similarly, current smokers with HPV- tumors (HR = 6.80, 95% CI = 1.11-41.67) had increased mortality compared to never/former smokers.

CONCLUSIONS

Current smoking is associated with poor prognosis, independent of HPV status, in CCRT-treated OPSCC patients. Current smoking produced an approximately four- to sevenfold increase in risk of mortality for HPV+ and HPV- patients, respectively. Regardless of pack years and HPV status, efforts should be made to achieve smoking cessation before CCRT.

LEVEL OF EVIDENCE: 4. Laryngoscope, 126:2733-2738, 2016.

Для цитирования: Platek Alexis J, Jayaprakash Vijayvel, Merzianu Mihai, Platek Mary E, Cohan David M, Hicks Wesley L, Marimuthu Sathiya P, Winslow Timothy B, Gupta Vishal, Arshad Hassan, Kuriakose Moni A, Dibaj Shiva, Marshall James R, Reid Mary E, Warren Graham W, Singh Anurag K. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.. The Laryngoscope. 2016. DOI: 10.1002/lary.26083.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.